BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab.[2017][Am J Hematol][10.1002ajh.24701]
本文档由 febday 分享于2017-03-11 16:42
BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab.[2017][Am J Hematol][10.1002ajh.24701]
下载文档
收藏
打印
分享:
君,已阅读到文档的结尾了呢~~